Clinical Trial Landscape in India Webinar Series – Part 1 -Worldwide Regulatory Landscape: Current (DIA Webinar)

Venue: Webinar

Location: Horsham, United States

Event Date/Time: Jul 15, 2009 End Date/Time: Jul 15, 2009
Report as Spam


Part 1 of "Clinical Trial Landscape in India" Webinar Series

India has been one of the major global players in the development of generic drugs, continues togain visibility

in the development of new drugs, and is one of the major geographies for conducting multinational clinical

trials. Learn how intergovernmental initiatives and partnerships between India’s Drug Regulatory Department

(DCGI office) and USFDA, Health Canada, MHRA and EMEA would add to India’s role in the development of new


Learning Objectives
At the conclusion of this webinar, participants should be able to:
  • Identify initiatives taken by FDA, EMEA, MHRA and Health Canada with DCGI office
  • Recognize

    what potential impact these initiatives may have in the advancement of clinical research
  • Discuss

    potential future initiatives

Target Audience
Professionals involved in:
  • Academia
  • Biostatistics
  • Clinical research and development
  • Clinical safety

    and pharmacovigilance
  • Clinical supply operations
  • Clinical trial and project management

  • Data management
  • Drug development and discovery
  • Investigator site management

  • Medical and scientific affairs
  • Outsourcing management/contract research organizations (CROs)

  • Pre-clinical development
  • Post-graduate studies
  • Procurement and purchasing

  • Quality assurance
  • Research and development
  • Strategic sourcing/planning

  • Regulatory affairs
  • Government and public policy
  • Senior- and executive-level decision

    makers for clinical trials

Speakers Include
  • Satish C. Tripathi, PhD, MPharm, MS, RAC
    President and CEO
    Biomedical Consulting International, Inc., United States
  • Albinus M D'Sa
    Compliance Officer
    FDA/CDER, United States
  • Gopalan Narayanan, MD
    Head, Biologicals and Biotechnology Unit
    MHRA, United Kingdom
  • Supriya Sharma, MD, MPH, FRCPC
    Director General, Health Products and Food Branch
    Health Canada, Canada

Please Click Here for more information.

Or contact JoAnn Boileau at the DIA office in Horsham, PA by telephone +1-215-442-6175, fax +1-215-442-6199, or


Event Code: